
Prelude Therapeutics names Lim as permanent CFO
WILMINGTON — Prelude Therapeutics has named Bryant Lim as its next chief financial officer, a role he has been serving in on an interim basis since April 2024. His position became official on Feb. 4. Lim had stepped in the role after Prelude’s previous top …